ROS-Dependent Neuroprotective Effects of NaHS in Ischemia Brain Injury Involves the PARP/AIF Pathway

Cellular Physiology and Biochemistry

Volumn 36, Issue 4, 2015, Pages 1539-1551

  Yu, Qian ^a   Lu, Zhihong ^b   Tao, Lei ^a   Yang, Lu ^a   Guo, Yu ^a   Yang, Yonghui ^a   Sun, Xude ^a   Ding, Qian ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Ischemia Reperfusion; NaHS; Neuroprotective; ROS

Indexed keywords

GLUTATHIONE PEROXIDASE; HYDROGEN SULFIDE; MALONALDEHYDE; NEUROPROTECTIVE AGENT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; SODIUM HYDROSULFIDE; SUPEROXIDE DISMUTASE; TRIPHENYLTETRAZOLIUM; UNCLASSIFIED DRUG; ANTIOXIDANT; SODIUM BISULFIDE; SULFIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CORTEX; BRAIN DAMAGE; BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN TISSUE; CELL FRACTIONATION; CELL VIABILITY; CHROMATIN CONDENSATION; CONTROLLED STUDY; DNA DAMAGE; IN VITRO STUDY; IN VIVO STUDY; MALE; MIDDLE CEREBRAL ARTERY; MIDDLE CEREBRAL ARTERY OCCLUSION; MITOCHONDRIAL MEMBRANE POTENTIAL; NERVE CELL; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; RAT; REPERFUSION INJURY; ANIMAL; BRAIN; BRAIN INJURIES; CELL LINE; COMPLICATION; DRUG EFFECTS; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; ANTIOXIDANTS; BRAIN; BRAIN INJURIES; BRAIN ISCHEMIA; CELL LINE; HYDROGEN SULFIDE; MALE; NEUROPROTECTIVE AGENTS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY; SULFIDES;

EID: 84936976581     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000430317     Document Type: Article

References (41)

1. Green AR: Protecting the brain: The search for a clinically effective neuroprotective drug for stroke. Crit Rev Neurobiol 2004;16:91-97.
2. Hallenbeck JM, Dutka AJ: Background review and current concepts of reperfusion injury. Arch Neurol 1990;47:1245-1254.
3. Cheng YD, Al-Khoury L, Zivin JA: Neuroprotection for ischemic stroke: Two decades of success and failure. NeuroRx 2004;1:36-45.
4. Lowicka E, Beltowski J: Hydrogen sulfide (H2S) - The third gas of interest for pharmacologists. Pharmacol Rep 2007;59:4-24.
5. Guo R, Wu K, Chen J, Mo L, Hua X, Zheng D, Chen P, Chen G, Xu W, Feng J: Exogenous hydrogen sulfide protects against doxorubicin-induced inflammation and cytotoxicity by inhibiting p38MAPK/NFB pathway in H9c2 cardiac cells. Cell Physiol Biochem 2013;32:1668-1680.
6. Avanzato D, Merlino A, Porrera S, Wang R, Munaron L, Mancardi D: Role of calcium channels in the protective effect of hydrogen sulfide in rat cardiomyoblasts. Cell Physiol Biochem 2014;33:1205-1214.
7. Han Y, Zeng F, Tan G, Yang C, Tang H, Luo Y, Feng J, Xiong H, Guo Q: Hydrogen sulfide inhibits abnormal proliferation of lymphocytes via AKT/GSK3 signal pathway in systemic lupus erythematosus patients. Cell Physiol Biochem 2013;31:795-804.
8. Yang CT, Zhao Y, Xian M, Li JH, Dong Q, Bai HB, Xu JD, Zhang MF: A novel controllable hydrogen sulfide-releasing molecule protects human skin keratinocytes against methylglyoxal-induced injury and dysfunction. Cell Physiol Biochem 2014;34:1304-1317.
9. Kimura Y, Goto Y, Kimura H: Hydrogen sulfide increases glutathione production and suppresses oxidative stress in mitochondria. Antioxid Redox Signal 2010;12:1-13.
10. Minamishima S, Bougaki M, Sips PY, Yu JD, Minamishima YA, Elrod JW, Lefer DJ, Bloch KD, Ichinose F: Hydrogen sulfide improves survival after cardiac arrest and cardiopulmonary resuscitation via a nitric oxide synthase 3-dependent mechanism in mice. Circulation 2009;120:888-896.
11. Johansen D, Ytrehus K, Baxter GF: Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemia-reperfusion injury-Evidence for a role of K ATP channels. Basic Res Cardiol 2006;101:53-60.
12. Liu H, Bai XB, Shi S, Cao YX: Hydrogen sulfide protects from intestinal ischaemia-reperfusion injury in rats. J Pharm Pharmacol 2009;61:207-212.
13. Kang K, Zhao M, Jiang H, Tan G, Pan S, Sun X: Role of hydrogen sulfide in hepatic ischemia-reperfusion-induced injury in rats. Liver Transpl 2009;15:1306-1314.
14. Yin J, Tu C, Zhao J, Ou DM, Chen GW, Liu Y, Xiao XZ: Exogenous hydrogen sulfide protects against global cerebral ischemia/reperfusion injury via its anti-oxidative, anti-inflammatory and anti-apoptotic effects in rats. Brain Research 2013;1491:188-196.
15. Chen J, Li Y, Wang L, Zhang Z, Lu D, Lu M, Chopp M: Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 2001;32:1005-1011.
16. Kramer M, Dang J, Baertling F, Denecke B, Clarner T, Kirsch C, Beyer C, Kipp M: TTC staining of damaged brain areas after MCA occlusion in the rat does not constrict quantitative gene and protein analyses. J Neurosci Methods 2010;187:84-89.
17. Buege JA, Aust SD: Microsomal lipid peroxidation. Methods Enzymol 1978;52:302-310.
18. Gao XY, Huang JO, Hu YF, Gu Y, Zhu SZ, Huang KB, Chen JY, Pan SY: Combination of mild hypothermia with neuroprotectants has greater neuroprotective effects during oxygen-glucose deprivation and reoxygenation-mediated neuronal injury. Sci Rep 2014;4:7091.
19. Xu H, Luo P, Zhao Y, Zhao M, Yang Y, Chen T, Huo K, Han H, Fei Z: Iduna protects HT22 cells from hydrogen peroxide-induced oxidative stress through interfering poly(ADP-ribose) polymerase-1-induced cell death (parthanatos). Cell Signal 2013;25:1018-1026.
20. Zhang Y, Zhang X, Park TS, Gidday JM: Cerebral endothelial cell apoptosis after ischemia-reperfusion: role of PARP activation and AIF translocation. J Cereb Blood Flow Metab 2005;25:868-877.
21. Liu Y, Cheng H, Zhou Y, Zhu Y, Bian R, Chen Y, Li C, Ma Q, Zheng Q, Zhang Y, Jin H, Wang X, Chen Q, Zhu D: Myostatin induces mitochondrial metabolic alteration and typical apoptosis in cancer cells. Cell Death Dis 2013;4:e494.
22. Chen H, Yoshioka H, Kim GS, Jung JE, Okami N, Sakata H, Maier CM, Narasimhan P, Goeders CE, Chan PH: Oxidative stress in ischemic brain damage: mechanisms of cell death and potential molecular targets for neuroprotection. Antioxid Redox Signal 2011;14:1505-1517.
23. Sanderson TH, Reynolds CA, Kumar R, Przyklenk K, Huttemann M: Molecular mechanisms of ischemia-reperfusion injury in brain: pivotal role of the mitochondrial membrane potential in reactive oxygen species generation. Mol Neurobiol 2013;47:9-23.
24. Shen Y, Guo W, Wang Z, Zhang Y, Zhong L, Zhu Y: Protective effects of hydrogen sulfide in hypoxic human umbilical vein endothelial cells: A possible mitochondria-dependent pathway. Int J Mol Sci 2013;14:13093-13108.
25. Niizuma K, Endo H, Chan PH: Oxidative stress and mitochondrial dysfunction as determinants of ischemic neuronal death and survival. J Neurochem 2009;109:133-138.
26. Lesnefsky EJ, Moghaddas S, Tandler B, Kerner J, Hoppel CL: Mitochondrial dysfunction in cardiac disease: ischemia-reperfusion, aging, and heart failure. J Mol Cell Cardiol 2001;33:1065-1089.
27. Rouslin W: Mitochondrial complexes I, II, III, IV, and V in myocardial ischemia and autolysis. Am J Physiol 1983;244:H743-748.
28. Lesnefsky EJ, Tandler B, Ye J, Slabe TJ, Turkaly J, Hoppel CL: Myocardial ischemia decreases oxidative phosphorylation through cytochrome oxidase in subsarcolemmal mitochondria. Am J Physiol 1997;273:H1544-1554.
29. Lucas DT, Szweda LI: Declines in mitochondrial respiration during cardiac reperfusion: Age-dependent inactivation of alpha-ketoglutarate dehydrogenase. Proc Natl Acad Sci U S A 1999;96:6689-6693.
30. Kimura H: Hydrogen sulfide and polysulfides as biological mediators. Molecules 2014;19:16146-16157.
31. Haramaki N, Stewart DB, Aggarwal S, Ikeda H, Reznick AZ, Packer L: Networking antioxidants in the isolated rat heart are selectively depleted by ischemia-reperfusion. Free Radic Biol Med 1998;25:329-339.
32. Ikejima M, Noguchi S, Yamashita R, Ogura T, Sugimura T, Gill DM, Miwa M: The zinc fingers of human poly(ADP-ribose) polymerase are differentially required for the recognition of DNA breaks and nicks and the consequent enzyme activation. Other structures recognize intact DNA. J Biol Chem 1990;265:21907-21913.
33. Ha HC, Snyder SH: Poly(ADP-ribose) polymerase-1 in the nervous system. Neurobiol Dis 2000;7:225-239.
34. Yoon YS, Kim JW, Kang KW, Kim YS, Choi KH, Joe CO: Poly(ADP-ribosyl)ation of histone H1 correlates with internucleosomal DNA fragmentation during apoptosis. J Biol Chem 1996;271:9129-9134.
35. Endres M, Wang ZQ, Namura S, Waeber C, Moskowitz MA: Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. J Cereb Blood Flow Metab 1997;17:1143-1151.
36. Pieper AA, Walles T, Wei G, Clements EE, Verma A, Snyder SH, Zweier JL: Myocardial postischemic injury is reduced by polyADPripose polymerase-1 gene disruption. Mol Med 2000;6:271-282.
37. Liaudet L, Soriano FG, Szabo E, Virag L, Mabley JG, Salzman AL, Szabo C: Protection against hemorrhagic shock in mice genetically deficient in poly(ADP-ribose)polymerase. Proc Natl Acad Sci U S A 2000;97:10203-10208.
38. Hansen TM, Nagley P: AIF: A multifunctional cog in the life and death machine. Sci STKE 2003;2003:PE31.
39. Hong SJ, Dawson TM, Dawson VL: Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signaling. Trends Pharmacol Sci 2004;25:259-264.
40. Boysen G, Brander T, Christensen H, Gideon R, Truelsen T: Homocysteine and risk of recurrent stroke. Stroke 2003;34:1258-1261.
41. Qu K, Chen CP, Halliwell B, Moore PK, Wong PT: Hydrogen sulfide is a mediator of cerebral ischemic damage. Stroke 2006;37:889-893.